MRNA logo

Moderna, Inc. (MRNA) Net Income

Annual Net Income:

-$3.56B+$1.15B(+24.46%)
December 31, 2024

Summary

  • As of today, MRNA annual net profit is -$3.56 billion, with the most recent change of +$1.15 billion (+24.46%) on December 31, 2024.
  • During the last 3 years, MRNA annual net income has fallen by -$15.76 billion (-129.18%).
  • MRNA annual net income is now -129.18% below its all-time high of $12.20 billion, reached on December 31, 2021.

Performance

MRNA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAincome statement metrics

Quarterly Net Income:

-$825.00M+$146.00M(+15.04%)
June 30, 2025

Summary

  • As of today, MRNA quarterly net profit is -$825.00 million, with the most recent change of +$146.00 million (+15.04%) on June 30, 2025.
  • Over the past year, MRNA quarterly net income has increased by +$454.00 million (+35.50%).
  • MRNA quarterly net income is now -116.95% below its all-time high of $4.87 billion, reached on December 31, 2021.

Performance

MRNA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAincome statement metrics

TTM Net Income:

-$2.90B+$454.00M(+13.52%)
June 30, 2025

Summary

  • As of today, MRNA TTM net profit is -$2.90 billion, with the most recent change of +$454.00 million (+13.52%) on June 30, 2025.
  • Over the past year, MRNA TTM net income has increased by +$2.96 billion (+50.52%).
  • MRNA TTM net income is now -119.83% below its all-time high of $14.64 billion, reached on March 31, 2022.

Performance

MRNA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

MRNA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+24.5%+35.5%+50.5%
3Y3 Years-129.2%-137.6%-120.7%
5Y5 Years-592.8%-606.9%-384.8%

MRNA Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-129.2%+24.5%-156.3%+77.3%-124.7%+51.4%
5Y5-Year-129.2%+24.5%-117.0%+77.3%-119.8%+51.4%
All-TimeAll-Time-129.2%+24.5%-117.0%+77.3%-119.8%+51.4%

MRNA Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$825.00M(+15.0%)
-$2.90B(+13.5%)
Mar 2025
-
-$971.00M(+13.3%)
-$3.36B(+5.7%)
Dec 2024
-$3.56B(+24.5%)
-$1.12B(-8715.4%)
-$3.56B(-60.1%)
Sep 2024
-
$13.00M(+101.0%)
-$2.22B(+62.1%)
Jun 2024
-
-$1.28B(-8.9%)
-$5.87B(+1.7%)
Mar 2024
-
-$1.18B(-641.5%)
-$5.97B(-26.6%)
Dec 2023
-$4.71B(-156.4%)
$217.00M(+106.0%)
-$4.71B(-36.0%)
Sep 2023
-
-$3.63B(-163.0%)
-$3.47B(-387.2%)
Jun 2023
-
-$1.38B(-1846.8%)
$1.21B(-74.8%)
Mar 2023
-
$79.00M(-94.6%)
$4.78B(-42.8%)
Dec 2022
$8.36B(-31.5%)
$1.47B(+40.5%)
$8.36B(-28.9%)
Sep 2022
-
$1.04B(-52.5%)
$11.77B(-16.3%)
Jun 2022
-
$2.20B(-39.9%)
$14.05B(-4.0%)
Mar 2022
-
$3.66B(-24.9%)
$14.64B(+20.0%)
Dec 2021
$12.20B(+1733.3%)
$4.87B(+46.1%)
$12.20B(+72.8%)
Sep 2021
-
$3.33B(+19.9%)
$7.06B(+102.1%)
Jun 2021
-
$2.78B(+127.7%)
$3.49B(+484.3%)
Mar 2021
-
$1.22B(+548.1%)
$598.17M(+180.1%)
Dec 2020
-$747.06M(-45.3%)
-$272.49M(-16.6%)
-$747.06M(-24.8%)
Sep 2020
-
-$233.64M(-100.2%)
-$598.82M(-22.6%)
Jun 2020
-
-$116.71M(+6.1%)
-$488.40M(+3.6%)
Mar 2020
-
-$124.23M(+0.0%)
-$506.63M(+1.6%)
Dec 2019
-$514.02M(-32.2%)
-$124.24M(-0.8%)
-$514.97M(+3.2%)
Sep 2019
-
-$123.22M(+8.7%)
-$532.16M(-8.8%)
Jun 2019
-
-$134.94M(-1.8%)
-$489.27M(-10.0%)
Mar 2019
-
-$132.58M(+6.3%)
-$444.93M(-15.6%)
Dec 2018
-$388.86M(-51.9%)
-$141.43M(-76.1%)
-$384.73M(-36.8%)
Sep 2018
-
-$80.33M(+11.3%)
-$281.25M(-5.9%)
Jun 2018
-
-$90.60M(-25.2%)
-$265.70M(-50.7%)
Mar 2018
-
-$72.38M(-90.7%)
-$176.27M(-67.9%)
Dec 2017
-$255.92M(-18.4%)
-$37.94M(+41.4%)
-$104.98M(-55.5%)
Sep 2017
-
-$64.78M(-5431.3%)
-$67.53M(-2270.8%)
Jun 2017
-
-$1.17M(-8.2%)
-$2.85M(-57.7%)
Mar 2017
-
-$1.08M(-118.5%)
-$1.81M(-115.6%)
Dec 2016
-$216.21M(-6579.2%)
-
-
Dec 2016
-
-$495.60K(-401.1%)
-$837.90K(-484.9%)
Sep 2016
-
-$98.90K(+23.5%)
$217.70K(-87.7%)
Jun 2016
-
-$129.20K(-13.1%)
$1.78M(-36.8%)
Mar 2016
-
-$114.20K(-120.4%)
$2.81M(-15.8%)
Dec 2015
$3.34M(+151.5%)
$560.00K(-61.6%)
$3.34M(-61.1%)
Sep 2015
-
$1.46M(+61.4%)
$8.58M(>+9900.0%)
Jun 2015
-
$904.00K(+118.4%)
-$2000.00(-100.1%)
Mar 2015
-
$414.00K(-92.9%)
$3.02M(+146.5%)
Dec 2014
-$6.48M(-312.3%)
$5.80M(+181.5%)
-$6.48M(+54.5%)
Sep 2014
-
-$7.12M(-281.7%)
-$14.24M(-75.9%)
Jun 2014
-
$3.92M(+143.2%)
-$8.10M(+32.7%)
Mar 2014
-
-$9.08M(-362.2%)
-$12.03M(-665.4%)
Dec 2013
-$1.57M(+83.5%)
-$1.96M(-101.2%)
-$1.57M(+57.1%)
Sep 2013
-
-$976.00K(>-9900.0%)
-$3.66M(+17.5%)
Jun 2013
-
-$7000.00(-100.5%)
-$4.43M(-32.5%)
Mar 2013
-
$1.38M(+134.0%)
-$3.35M(+64.9%)
Dec 2012
-$9.55M(+67.6%)
-$4.05M(-131.5%)
-$9.55M(+59.0%)
Sep 2012
-
-$1.75M(-262.0%)
-$23.28M(+10.2%)
Jun 2012
-
$1.08M(+122.4%)
-$25.92M(+15.3%)
Mar 2012
-
-$4.82M(+72.9%)
-$30.58M(-3.9%)
Dec 2011
-$29.42M(-6.0%)
-$17.79M(-305.4%)
-$29.42M(-67.9%)
Sep 2011
-
-$4.39M(-22.4%)
-$17.53M(+18.1%)
Jun 2011
-
-$3.58M(+2.2%)
-$21.41M(+2.4%)
Mar 2011
-
-$3.67M(+37.8%)
-$21.93M(+21.0%)
Dec 2010
-$27.75M
-$5.89M(+28.8%)
-$27.75M(-22.5%)
Sep 2010
-
-$8.27M(-101.7%)
-$22.65M(-5.9%)
Jun 2010
-
-$4.10M(+56.8%)
-$21.39M(+13.8%)
DateAnnualQuarterlyTTM
Mar 2010
-
-$9.49M(-1108.9%)
-$24.82M(-208.4%)
Dec 2009
-$8.05M(+86.4%)
-$785.00K(+88.8%)
-$8.05M(+58.9%)
Sep 2009
-
-$7.01M(+6.9%)
-$19.56M(+31.7%)
Jun 2009
-
-$7.53M(-203.4%)
-$28.62M(+19.2%)
Mar 2009
-
$7.28M(+159.2%)
-$35.42M(+40.2%)
Dec 2008
-$59.22M(-13.1%)
-$12.30M(+23.5%)
-$59.22M(-0.5%)
Sep 2008
-
-$16.07M(-12.1%)
-$58.93M(+0.6%)
Jun 2008
-
-$14.33M(+13.2%)
-$59.31M(-3.4%)
Mar 2008
-
-$16.52M(-37.5%)
-$57.35M(-9.5%)
Dec 2007
-$52.37M(-94.9%)
-$12.02M(+27.0%)
-$52.37M(-2.7%)
Sep 2007
-
-$16.45M(-33.0%)
-$51.02M(-20.4%)
Jun 2007
-
-$12.37M(-7.2%)
-$42.38M(-38.6%)
Mar 2007
-
-$11.54M(-8.2%)
-$30.57M(-13.7%)
Dec 2006
-$26.88M(+16.4%)
-$10.66M(-36.6%)
-$26.88M(-6.9%)
Sep 2006
-
-$7.81M(-1294.3%)
-$25.13M(+3.8%)
Jun 2006
-
-$560.00K(+92.9%)
-$26.14M(+22.9%)
Mar 2006
-
-$7.85M(+12.0%)
-$33.92M(-5.5%)
Dec 2005
-$32.16M(-12.4%)
-$8.92M(-1.2%)
-$32.16M(-10.3%)
Sep 2005
-
-$8.81M(-5.6%)
-$29.16M(-4.5%)
Jun 2005
-
-$8.34M(-37.1%)
-$27.91M(-3.2%)
Mar 2005
-
-$6.09M(-2.8%)
-$27.05M(+5.4%)
Dec 2004
-$28.61M(-1236.2%)
-$5.92M(+21.7%)
-$28.61M(-0.0%)
Sep 2004
-
-$7.55M(-0.9%)
-$28.61M(-4.8%)
Jun 2004
-
-$7.49M(+2.0%)
-$27.30M(-298.0%)
Mar 2004
-
-$7.64M(-29.2%)
-$6.86M(-220.4%)
Dec 2003
-$2.14M(+84.1%)
-$5.92M(+5.3%)
-$2.14M(-6.0%)
Sep 2003
-
-$6.25M(-148.3%)
-$2.02M(-344.7%)
Jun 2003
-
$12.95M(+542.8%)
$825.00K(+106.1%)
Mar 2003
-
-$2.92M(+49.5%)
-$13.59M(-0.9%)
Dec 2002
-$13.47M(-45.9%)
-$5.79M(-70.1%)
-$13.47M(-25.9%)
Sep 2002
-
-$3.41M(-132.4%)
-$10.70M(-17.4%)
Jun 2002
-
-$1.47M(+47.7%)
-$9.12M(+6.1%)
Mar 2002
-
-$2.80M(+7.4%)
-$9.71M(-5.3%)
Dec 2001
-$9.23M(+4.7%)
-$3.03M(-65.8%)
-$9.23M(-23.5%)
Sep 2001
-
-$1.82M(+11.5%)
-$7.47M(+22.5%)
Jun 2001
-
-$2.06M(+10.9%)
-$9.64M(+1.9%)
Mar 2001
-
-$2.31M(-82.4%)
-$9.83M(-1.5%)
Dec 2000
-$9.69M(-15.4%)
-$1.27M(+68.2%)
-$9.69M(+13.6%)
Sep 2000
-
-$4.00M(-77.4%)
-$11.22M(-23.0%)
Jun 2000
-
-$2.25M(-3.6%)
-$9.13M(-10.3%)
Mar 2000
-
-$2.17M(+22.4%)
-$8.27M(+0.3%)
Dec 1999
-$8.40M(-833.3%)
-$2.80M(-47.4%)
-$8.30M(-23.9%)
Sep 1999
-
-$1.90M(-35.7%)
-$6.70M(-34.0%)
Jun 1999
-
-$1.40M(+36.4%)
-$5.00M(-47.1%)
Mar 1999
-
-$2.20M(-83.3%)
-$3.40M(-240.0%)
Dec 1998
-$900.00K(+80.0%)
-$1.20M(-500.0%)
-$1.00M(+41.2%)
Sep 1998
-
-$200.00K(-200.0%)
-$1.70M(+39.3%)
Jun 1998
-
$200.00K(0.0%)
-$2.80M(+28.2%)
Mar 1998
-
$200.00K(+110.5%)
-$3.90M(+13.3%)
Dec 1997
-$4.50M(-1025.0%)
-$1.90M(-46.2%)
-$4.50M(-73.1%)
Sep 1997
-
-$1.30M(-44.4%)
-$2.60M(-116.7%)
Jun 1997
-
-$900.00K(-125.0%)
-$1.20M(-300.0%)
Mar 1997
-
-$400.00K(-500.0%)
-$300.00K(-400.0%)
Dec 1996
-$400.00K(-500.0%)
-
-
Sep 1996
-
$100.00K(-50.0%)
$100.00K(+150.0%)
Jun 1996
$100.00K(+200.0%)
-
-
Mar 1996
-
$200.00K(+200.0%)
-$200.00K(+50.0%)
Dec 1995
-
-$200.00K(0.0%)
-$400.00K(-300.0%)
Jun 1995
-$100.00K(-150.0%)
-$200.00K(-300.0%)
-$100.00K(-150.0%)
Sep 1994
-
$100.00K(0.0%)
$200.00K(-33.3%)
Jun 1994
$200.00K
$100.00K(-50.0%)
$300.00K(+50.0%)
Sep 1993
-
$200.00K
$200.00K

FAQ

  • What is Moderna, Inc. annual net profit?
  • What is the all-time high annual net income for Moderna, Inc.?
  • What is Moderna, Inc. annual net income year-on-year change?
  • What is Moderna, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Moderna, Inc.?
  • What is Moderna, Inc. quarterly net income year-on-year change?
  • What is Moderna, Inc. TTM net profit?
  • What is the all-time high TTM net income for Moderna, Inc.?
  • What is Moderna, Inc. TTM net income year-on-year change?

What is Moderna, Inc. annual net profit?

The current annual net income of MRNA is -$3.56B

What is the all-time high annual net income for Moderna, Inc.?

Moderna, Inc. all-time high annual net profit is $12.20B

What is Moderna, Inc. annual net income year-on-year change?

Over the past year, MRNA annual net profit has changed by +$1.15B (+24.46%)

What is Moderna, Inc. quarterly net profit?

The current quarterly net income of MRNA is -$825.00M

What is the all-time high quarterly net income for Moderna, Inc.?

Moderna, Inc. all-time high quarterly net profit is $4.87B

What is Moderna, Inc. quarterly net income year-on-year change?

Over the past year, MRNA quarterly net profit has changed by +$454.00M (+35.50%)

What is Moderna, Inc. TTM net profit?

The current TTM net income of MRNA is -$2.90B

What is the all-time high TTM net income for Moderna, Inc.?

Moderna, Inc. all-time high TTM net profit is $14.64B

What is Moderna, Inc. TTM net income year-on-year change?

Over the past year, MRNA TTM net profit has changed by +$2.96B (+50.52%)
On this page